Victory Capital Management
HARP

Victory Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Victory Capital Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-196
Closed -$23K – 3473
2020
Q1 		$23K Buy
+196
New +$27.6K ﹤0.01% 2803
2019
Q4 		– Sell
-176
Closed -$24K – 3458
2019
Q3 		$24K Buy
+176
New +$24.7K ﹤0.01% 2988

Other funds holding HARP

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management's HARP Position: Q2 2020 in Review

Victory Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q2 2020, closing a stake of 196 shares — an estimated $23K sold.

Victory Capital Management first reported a position in HARP in Q3 2019 and held it in 2 quarters. The position peaked at $24K in Q3 2019. 69 funds tracked by Wall St. Rank hold HARP as of Q2 2020.

  • Victory Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 196 Harpoon Therapeutics, Inc. Common Stock shares in Q2 2020, an estimated $23K.
  • Victory Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $24K in Q3 2019.
  • 69 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.